Jivanu Therapeutics Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2023.
2023 Mumbai, Maharashtra, India Active
Last Updated:
About Jivanu Therapeutics Private Limited

Jivanu Therapeutics Private Limited, a active private limited company, was established on 02 June 2023 in Mumbai, Maharashtra, India. it holds CIN: U86909MH2023PTC404172. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.

Its leadership includes Anil D Kini (Director), Usha Ashok Shukla (Director). Past directors included Anil D Kini, Baijnath Prasad Rai. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 403 A Nirman Vihar, Pump House R J Marg, Mumbai, Maharashtra, 400093.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U86909MH2023PTC404172

  • Registration Number

    404172

  • Incorporation Date

    02 June 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 2 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Jivanu Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jivanu Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jivanu Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Anil D Kini Director 01 Feb 2024 Current
Usha Ashok Shukla Director 02 Jun 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Sep 2024 Past
Pramod Abcsdd Director 19 May 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jivanu Therapeutics.

Enhance accessibility to Jivanu Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Jivanu Therapeutics revenue growth over time
Jivanu Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jivanu Therapeutics?

Unlock access to Jivanu Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Jivanu Therapeutics?

Unlock and access historical data on people associated with Jivanu Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jivanu Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jivanu Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jivanu Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Jivanu Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Jivanu Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Director Appointment

    The activity Anil D Kini was appointed as a Director was appointed as a Director on 01 Feb 2024 & has been associated with this company since 2 years 1 month . was completed.

  • Director Appointment

    The activity Usha Ashok Shukla was appointed as a Director was appointed as a Director on 02 Jun 2023 & has been associated with this company since 2 years 9 months . was completed.

  • Company Incorporation

    Progress on Jivanu Therapeutics Private Limited was registered on 02 Jun 2023 with Roc Mumbai I & aged 2 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jivanu Therapeutics Private Limited?

The CIN of Jivanu Therapeutics Private Limited is U86909MH2023PTC404172.

Where is Jivanu Therapeutics Private Limited headquartered?

Jivanu Therapeutics Private Limited is headquartered at 403 A Nirman Vihar, Pump House R J Marg, Mumbai, Maharashtra, 400093.

When was Jivanu Therapeutics Private Limited incorporated?

Jivanu Therapeutics Private Limited was incorporated on 02 June 2023.

Who are the current directors of Jivanu Therapeutics Private Limited?

The current directors of Jivanu Therapeutics Private Limited are

Is Jivanu Therapeutics Private Limited a listed company?

Jivanu Therapeutics Private Limited is unlisted.

What is the capital structure of Jivanu Therapeutics Private Limited?

The authorized capital of Jivanu Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available